← Back to patent-cliff list
MK-7762
Tier C — Watch / tradeMK-7762
Merck & Co Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：Pulmonary tuberculosis, Mycobacterium tuberculosis infection
Regional status
US
Phase I
2023-02-23
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of MK-7762?
Approved indications include: Pulmonary tuberculosis, Mycobacterium tuberculosis infection.
When does the MK-7762 patent expire?
No public expiry year is available for MK-7762 yet; this page updates once verified.
How do I get a quote for MK-7762 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29